| Line Item | 2024-10-31 | Y/Y |
|---|---|---|
| R&D Expense | $38.3M | +132.8% |
| SG&A Expense | $24.0M | +149.8% |
| Operating Income | -$62.3M | -139.1% |
| Pre-tax Income | -$55.2M | +44.8% |
| Income Tax | -$19K | -211.8% |
| Net Income | -$55.1M | +44.8% |
| EPS (Basic) | $1.46 | -99.0% |
| EPS (Diluted) | $1.46 | -99.0% |
| Line Item | 2024-10-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $173.0M | +112.2% |
| Short-term Investments | $65.3M | — |
| Current Assets | $247.4M | +189.5% |
| Total Assets | $311.2M | +257.8% |
| Current Liabilities | $14.7M | +178.9% |
| Total Liabilities | $38.6M | +166.4% |
| Stockholders' Equity | $272.6M | +276.1% |
| Line Item | 2024-10-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$48.3M | -95.1% |
| Capital Expenditures | $925K | +190.9% |
| Investing Cash Flow | -$126.0M | — |
| Financing Cash Flow | $265.7M | +208.4% |
| Free Cash Flow | -$49.2M | -96.3% |